Document Preview Unavailable

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Achiron Anat; Mandel Mathilda; Dreyer-Alster Sapir; Harari, Gil; Magalashvili, David; et al.  Therapeutic Advances in Neurological Disorders Vol. 14,  (Jan 2021).

You might have access to this document